Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1401 - 1422 of 1422

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1651 - 1675 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Etanercept	cdr_SE0485_TBC.pdf SE0485_complete_Brenzys-Oct-27-16.pdf se0485_brenzys_pi.pdf se0485_brenzys_seb_report.pdf	Mar 9, 2016	Reimbursement Review	Complete	SE0485-000
Ixekizumab	TS0001-PsO-Updated-Streamlined-Rec.pdf cdr_SR0481_TBC.pdf SR0481_complete_Taltz-oct-27-16.pdf SR0481_Taltz_PI_Submissions.pdf SR0481_Taltz_CL_Report_e.pdf SR0481_Taltz_PE_Report_e.pdf	Feb 17, 2016	Reimbursement Review	Complete	SR0481-000
Selexipag	cdr_SR0482_Uptravi.pdf SR0482_complete_Uptravi-Oct-28-16.pdf SR0482_Uptravi_PI_Submissions.pdf SR0482_Uptravi_CL_Report_e.pdf SR0482_Uptravi_PE_Report.pdf	Feb 16, 2016	Reimbursement Review	Complete	SR0482-000
Drugs for Rare Diseases: Evolving Trends in Regulatory and Health Technology Assessment Perspectives	ES0300_Rare_Disease_Drugs_e.pdf	Feb 11, 2016	Health Technology Review		ES0300-000
Emtricitabine/tenofovir disoproxil fumarate	cdr_SR0479_Truvada.pdf SR0479_complete_Truvada_Aug-26-16.pdf SR0479_Truvada_CL_Report.pdf SR0479_Truvada_PE_Report.pdf SR0479_Truvada_PI_Submissions.pdf	Feb 4, 2016	Reimbursement Review	Complete	SR0479-000
Apremilast	cdr_SR0478_Otezla_Resub.pdf SR0478_complete_Otezla-Oct-28-16.pdf SR0478_Otezla_PI_Submissions.pdf SR0478_Otezla_CL_Report_e.pdf SR0478_Otezla_PE_Report_e.pdf	Jan 29, 2016	Reimbursement Review	Complete	SR0478-000
Secukinumab	cdr_SR0475_Cosentyx_AS.pdf SR0475_complete_Cosentyx_AS_Aug-25-16.pdf SR0475_CosentyxAS_CL_Report.pdf SR0475_CosentyxAS_PE_Report.pdf SR0475_CosentyxAS_PI_Submissions.pdf	Jan 21, 2016	Reimbursement Review	Complete	SR0475-000
Secukinumab	cdr_SR0476_Cosentyx_PsA.pdf SR0476_complete_Cosentyx_PsA_Aug-25-16.pdf SR0476_CosentyxPsA_CL_Report.pdf SR0476_CosentyxPsA_PE_Report.pdf SR0476_CosentyxPsA_PI_Submissions.pdf	Jan 21, 2016	Reimbursement Review	Complete	SR0476-000
Mifepristone and misoprostol	cdr_SR0473_Mifegymiso.pdf	Jan 18, 2016	Reimbursement Review	Withdrawn	SR0473 -000
sofosbuvir	cdr_SF0464_Sovaldi.pdf SF0464_complete_Sovaldi-May_19_16.pdf SF0464_Sovaldi_RfA_Review_Report.pdf SF0464_Sovaldi_RFA_PI_Submissions.pdf	Jan 6, 2016	Reimbursement Review	Complete	SF0464-000
ombitasvir/paritaprevir/ritonavir and dasabuvir	cdr_SF0466_Holkira_Pak.pdf SF0466_complete_Holkira_Pak_May-25-16.pdf SF0466_HolkiraPak_RfA_Review_Report.pdf SF0466_HolkiraPak_RfA_PI_Submissions.pdf	Jan 6, 2016	Reimbursement Review	Complete	SF0466-000
daclatasvir	cdr_SF0467_Daklinza.pdf SF0467_complete_Daklinza_May_25-16.pdf SF0467_Daklinza_RfA_Review_Report.pdf SF0467_Daklinza_RfA_PI_Submissions.pdf	Jan 6, 2016	Reimbursement Review	Complete	SF0467-000
Sapropterin dihydrochloride	cdr_SR0472_Kuvan.pdf SR0472_complete_Kuvan-Oct-28-16.pdf SR0472_Kuvan_PI_Submissions.pdf SR0472_Kuvan_CL_Report_e.pdf SR0472_Kuvan_PE_Report_e.pdf	Jan 4, 2016	Reimbursement Review	Complete	SR0472-000
Zykadia for Metastatic Non-Small Cell Lung Cancer - Details	pcodr_provfund_ceritinib_zykadia_nsclc.pdf pcodr_ceritinib_zykadia_nsclc_fn_rec.pdf pcodr_ceritinib_zykadia_nsclc_fn_cgr.pdf pcodr_ceritinib_zykadia_nsclc_fn_egr.pdf pcodr_ceritinib_zykadia_nsclc_in_rec.pdf pcodr_ceritinib_zykadia_nsclc_pagfdk.pdf pcodr_ceritinib_zykadia_nsclc_fdk_novartis.pdf pcodr_ceritinib_zykadia_nsclc_ptfdk_lcc.pdf pcodr_ceritinib_zykadia_nsclc_coi_lcc.pdf	Dec 18, 2015	Reimbursement Review	Complete	PC0062-000
Vectibix for mCRC – Details	pcodr_provfund_panitumumab_vectibix_mcrc.pdf pcodr_panitumumab_vectibix_mcrc_fn_rec.pdf pcodr_panitumumab_vectibix_mcrc_fn_cgr.pdf pcodr_panitumumab_vectibix_mcrc_fn_egr.pdf pcodr_panitumumab_vectibix_mcrc_in_rec.pdf pcodr_panitumumab_vectibix_mcrc_pagfdk.pdf pcodr_panitumumab_vectibix_mcrc_fdk_amgen.pdf pcodr_panitumumab_vectibix_mcrc_coi_ccac.pdf	Dec 18, 2015	Reimbursement Review	Complete	PC0060-000
Revlimid for Newly Diagnosed MM – Details	pcodr_provfund_lenalidomide_revlimid_nd-mm.pdf pcodr_lenalidomide_revlimid_nd-mm_fn_rec.pdf pcodr_lenalidomide_revlimid_nd-mm_fn_cgr.pdf pcodr_lenalidomide_revlimid_nd-mm_fn_egr.pdf pcodr_lenalidomide_revlimid_mm_in_rec.pdf pcodr_lenalidomide_revlimid_nd-mm_pagfdk.pdf pcodr_lenalidomide_revlimid_nd-mm_fdk_celgene.pdf pcodr_lenalidomide_revlimid_nd-mm_coi_mc.pdf	Dec 18, 2015	Reimbursement Review	Complete	PC0061-000
Alirocumab	cdr_SR0469_Praluent.pdf SR0469_complete_Praluent_Jul-20-16.pdf SR0469_Praluent_CL_Report.pdf SR0469_Praluent_PE_Report.pdf SR0469_Praluent_PI_Submissions.pdf	Dec 7, 2015	Reimbursement Review	Complete	SR0469-000
Keytruda for Metastatic Melanoma – Details	pcodr_provfund_pembrolizumab_keytruda_mm.pdf pcodr_pembrolizumab_keytruda_mm_fn_rec.pdf pcodr_pembrolizumab_keytruda_mm_fn_cgr.pdf pcodr_pembrolizumab_keytruda_mm_fn_egr.pdf pcodr_pembrolizumab_keytruda_mm_in_rec.pdf pcodr_pembrolizumab_keytruda_mm_pagfdk.pdf pcodr_pembrolizumab_keytruda_mm_fdk-merck.pdf pcodr_pembrolizumab_keytruda_mm_ptfdk_sysf.pdf pcodr_pembrolizumab_keytruda_mm_ptfdk_mnc.pdf pcodr_pembrolizumab_keytruda_mm_coi_sysf.pdf pcodr_pembrolizumab_keytruda_mm_coi_mnc.pdf pcodr_pembrolizumab_keytruda_mm_coi_cspa.pdf	Dec 1, 2015	Reimbursement Review	Complete	PC0058-000
Canakinumab	cdr_SR0463_Ilaris.pdf SR0463_Ilaris_sJIA_CL_Report.pdf SR0463_Ilaris_sJIA_PE_Report.pdf SR0463_complete_Ilaris_sJIA_June_21_16_e.pdf SR0463_Ilaris_SJIA_PI_Submissions.pdf	Nov 24, 2015	Reimbursement Review	Complete	SR0463-000
Mepolizumab	cdr_SR0461_Nucala.pdf SR0461_Nucala_CL_Report_e.pdf SR0461_Nucala_PE_Report_e.pdf SR0461_complete_Nucala_June-20-16_e.pdf SR0461_Nucala_PI_Submissions.pdf	Nov 20, 2015	Reimbursement Review	Complete	SR0461-000
Aflibercept	SR0460 Eylea.pdf SR0460_Eylea BRVO_complete_Jul-29_16.pdf SR0460_Eylea_BRVO_CL_Report.pdf SR0460_Eylea_BRVO_PE_Report.pdf	Nov 16, 2015	Reimbursement Review	Complete	SR0460-000
Avastin (with capecitabine) for Metastatic Colorectal Cancer - Details	pcodr_provfund_avastin-capecitabine_mcrc.pdf pcodr_avastin_capecitabine_mcrc_fn_rec.pdf pcodr_avastin_capecitabine_mcrc_fn_cgr.pdf pcodr_avastin_capecitabine_mcrc_fn_egr.pdf pcodr_avastin_capecitabine_mcrc_in_rec.pdf pcodr_avastin_capecitabine_mcrc_pagfdk.pdf pcodr_avastin_capecitabine_mcrc_fdk_roche.pdf pcodr_avastin_capecitabine_mcrc_ptfdk_ccac.pdf pcodr_avastin_capecitabine_mcrc_coi_ccac.pdf	Nov 13, 2015	Reimbursement Review	Complete	PC0055-000
Cyramza for Advanced GC or GEJ Adenocarcinoma – Details	pcodr_profund_ramucirumab_cyramza_gc.pdf pcodr_ramucirumab_cyramza_gc_fn_rec.pdf pcodr_ramucirumab_cyramza_gc_fn_cgr.pdf pcodr_ramucirumab_cyramza_gc_fn_egr.pdf pcodr_ramucirumab_cyramza_gc_in_rec.pdf pcodr_ramucirumab_cyramza_gc-pagfdk.pdf pcodr_ramucirumab_cyramza_gc-fdk-elc.pdf	Nov 13, 2015	Reimbursement Review	Complete	PC0059-000
teduglutide	cdr_SR0459_Revestive.pdf SR0459_Revestive_complete_Jul-29_16.pdf SR0459_Revestive_CL_Report.pdf SR0459_Revestive_PE_Report.pdf SR0459_Revestive_PI_Submissions.pdf	Oct 30, 2015	Reimbursement Review	Complete	SR0459-000
lumacaftor/ivacaftor	cdr_SR0471_Orkambi.pdf SR0471_complete_Orkambi-Oct-28-16.pdf SR0471_Orkambi_CL_Report.pdf SR0471_Orkambi_PE_Report.pdf SR0471_Orkambi_PI_Submissions.pdf	Oct 30, 2015	Reimbursement Review	Complete	SR0471-000